A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of a Human Monoclonal Antibody, REGN2222, for the Prevention of Medically-Attended RSV Infection in Preterm Infants
Supported projects > Other Supported Projects · 2016
Authors: Özge ALTUN, Elif Erol, Demet TEREK, Nalan Baltacı, Mehmet YALAZ
2016-2017, Other Supported Projects, R & D Project, Completed